Additionally, the diminished expression of SCARA3, which is negatively correlated with multiple myeloma prognosis[10] together with the aforementioned changes of gene expression in cells carrying the deletion might provide a platform that promotes myeloma cell survival. The gene discussed is SCARA3; the disease is plasma cell myeloma.